| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Intellia Therapeutics, Inc. (NTLA) has 14 insiders with recent SEC Form 4 filings, including 0 buys and 48 sells. NTLA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.01M | $14.47M | - | |
| Dir | 207.5K | $2.96M | - | |
| Dir | 134.7K | $1.92M | - | |
| VP | 121.2K | $1.73M | - | |
| VP | 101.5K | $1.45M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 5, 2021 | Crowley John F67 | Director | Sale+OE | 10,000 | $130.54 | $1,305,390.92 | -26.9% | -8.3% | -53.1% | |
| Sep 21, 2021 | Lebwohl David87 | EVP, Chief Medical Officer | Sale+OE | 2,400 | $149.81 | $359,544.00 | -75.2% | -17.0% | -59.7% | |
| Sep 7, 2021 | Goddard Glenn83 | EVP, Chief Financial Officer | Sale+OE | 3,482 | $180.12 | $627,177.84 | -100% | -38.3% | -64.7% | |
| Sep 1, 2021 | Leonard John M83 | President And CEO | Sale+OE | 121,372 | $160.83 | $19,520,418.44 | -1.5% | -29.9% | -63.4% | |
| Aug 31, 2021 | Goddard Glenn83 | EVP, Chief Financial Officer | Sale+OE | 30,000 | $159.45 | $4,783,537.56 | -70.1% | -30.4% | -62.6% | |
| Aug 30, 2021 | Sepp-Lorenzino Laura83 | EVP, Chief Scientific Officer | Sale+OE | 97,000 | $154.83 | $15,018,054.43 | -30.0% | -27.4% | -60.9% | |
| Aug 30, 2021 | Lebwohl David87 | EVP, Chief Medical Officer | Sale+OE | 2,400 | $158.04 | $379,300.00 | -21.0% | -27.4% | -60.9% | |
| Aug 23, 2021 | Leonard John M83 | President And CEO | Sale+OE | 27,139 | $152.01 | $4,125,416.16 | -1.2% | -21.1% | -61.7% | |
| Aug 19, 2021 | Leonard John M83 | President And CEO | Sale+OE | 22,682 | $151.28 | $3,431,397.94 | -1.0% | -6.7% | -60.9% | |
| Aug 9, 2021 | Lebwohl David87 | EVP, Chief Medical Officer | Sale+OE | 2,400 | $164.05 | $393,720.00 | -75.2% | -15.1% | -62.3% |